The Entre Ríos Senate approved and passed into law the bill that creates the regime for safe and informed access to cannabis for medical, therapeutic and/or palliative pain relief purposes and its derivatives, which seeks to “guarantee and promote the comprehensive protection of the health of people” who need it.
During the fifth ordinary session of the 142nd legislative period, the provincial legislators participated in person on Wednesday in the Chamber of Deputies of Entre Ríos, in order to maintain the necessary distance in the framework of the prevention measures due to the coronavirus.
The initiative, authored by Congresswoman Silvia Moreno and Congressman Néstor Loggio, seeks to “protect integral health, understood as a fundamental human right in the provincial territory, through the access to the cannabis plant and its derivatives.”
If you want to read more about the law regarding the cultivation of medical cannabis in Entre Rios and to find the most important cannabis news in the world, download for free the Hemp.im mobile app.
What does the cannabis law in Entre Rios says
The law authorizes to sow, cultivate, transport, store and produce cannabis and its derivatives to persons who cultivate for themselves or for a third party with medical recommendation for its therapeutic use; to the provincial State, municipalities, and communes; to governmental science and technology organizations; research centers; public laboratories; public universities; civil associations; foundations; mutual societies and cooperatives.
Likewise, commercial companies (private laboratories) are excluded, which will only be authorized to produce phytopreparations and magistral formulations, as well as their subsequent commercialization if they operate as pharmacies.
The provincial Ministry of Health will be the application authority, which will coordinate the implementation of public policies together with the Ministry of Production, Tourism and Economic Development of Entre Ríos.
The registry for cannabis cultivation in Entre Rios
Persons who cultivate, grow, transport, store and produce cannabis and its derivatives for themselves or for a third party are authorized to sow, cultivate, transport, store and produce cannabis and its derivatives.
Persons who cultivate for themselves or for a third party are authorized to sow, cultivate, transport, store and produce cannabis and its derivatives.
Individuals, civil associations and foundations will have to request an “official certification” to cultivate from the health portfolio; and organizations, laboratories, centers and associations will request a “license”, which will seek to “favor the popular economy, regional economies and accessibility” in the province.
Meanwhile, universities will be exempted from the need to request licenses.
The regulation also creates the “Provincial Registry of Pharmacies”, where pharmacies must register in order to produce and commercialize magistral formulations based on cannabis extracts, cannabinoids or vegetable raw material with pharmacological activity and its subsequent commercialization.
The program of access to cannabis of Entre Ríos (Pacer) is also created to “develop and implement promotion and prevention actions; generate, facilitate and guarantee information and training; guarantee free testing of phytopreparations to all authorized persons.
In this sense, it creates a voluntary registry of health professionals trained in the use of medicinal, therapeutic and palliative cannabis, which will be presented to patients who require it; and seeks to promote scientific research on the cannabis plant and its components.
The law guarantees free chromatographic testing for the quantification of cannabinoids in phytopreparations made by authorized human and legal persons; and creates the “Bank of cannabis oil, seeds and cannabis derivatives” that will provide seeds free of charge to the contemplated persons.
(Featured image by NickyPe via Pixabay)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in telam, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.